Daewoong Co., Ltd. (KRX:003090)

Market Cap	915.95B
Revenue (ttm)	1.97T
Net Income (ttm)	62.94B
Shares Out	40.89M
EPS (ttm)	1,539.39
PE Ratio	14.55
Forward PE	6.27
Dividend	200.00 (0.88%)
Ex-Dividend Date	Dec 27, 2024

Volume	122,204
Average Volume	216,815
Open	23,900
Previous Close	24,200
Day's Range	23,100 - 23,950
52-Week Range	15,050 - 28,650
Beta	1.07
RSI	42.10
Earnings Date	Aug 14, 2025

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam, South...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 356
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003090

Financial Performance

In 2024, Daewoong's revenue was 1.94 trillion, an increase of 6.79% compared to the previous year's 1.81 trillion. Earnings were 57.89 billion, a decrease of -62.08%.